Related Experiment Video
Updated: Jul 3, 2026

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
Published on: January 23, 2019
Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension
Nir Peled1, Daniele Bendayan, David Shitrit
1Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Systemic endothelial dysfunction is present in most pulmonary arterial hypertension (PAH) types, excluding Eisenmenger syndrome. This dysfunction correlates with increased disease severity in PAH patients.
Area of Science:
- Cardiovascular Research
- Pulmonary Hypertension
- Endothelial Biology
Background:
- Pulmonary endothelium is crucial in pulmonary arterial hypertension (PAH).
- Limited data exists on systemic endothelial involvement in PAH.
- This study investigates systemic endothelial function in various PAH types.
Purpose of the Study:
- To evaluate systemic endothelial function in patients with idiopathic, scleroderma-associated, chronic thromboembolic, and Eisenmenger PAH.
- To determine the correlation between systemic endothelial dysfunction and disease severity in PAH.
Main Methods:
- Assessed endothelial function using peripheral arterial tone (PAT) ratio in 54 PAH patients and 21 controls.
- Utilized non-invasive plethysmography to measure forearm blood flow response to brachial artery occlusion.
- Included clinical evaluation, pulmonary assessment, echocardiography, and cardiac stress testing.
Main Results:
- PAT ratio was significantly lower in idiopathic, scleroderma-associated, and chronic thromboembolic PAH compared to controls.
- The Eisenmenger PAH group showed no significant difference in PAT ratio compared to controls.
- Impaired hyperemic response correlated with increased NYHA classification, pulmonary pressure, and oxygen desaturation, and decreased 6-minute walking distance.
Conclusions:
- Systemic endothelial dysfunction is implicated in idiopathic, scleroderma-associated, and chronic thromboembolic PAH.
- Endothelial dysfunction in PAH is linked to disease severity.
- Further research into systemic endothelial involvement in PAH is warranted.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Peripheral Artery Disease IV: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

